Cutting Edge: Neuronal Recognition by CD8 T Cells Elicits Central Diabetes Insipidus

An increasing number of neurologic diseases is associated with autoimmunity. The immune effectors contributing to the pathogenesis of such diseases are often unclear. To explore whether self-reactive CD8 T cells could attack CNS neurons in vivo, we generated a mouse model in which the influenza virus hemagglutinin (HA) is expressed specifically in CNS neurons. Transfer of cytotoxic anti-HA CD8 T cells induced an acute but reversible encephalomyelitis in HA-expressing recipient mice. Unexpectedly, diabetes insipidus developed in surviving animals. This robust phenotype was associated with preferential accumulation of cytotoxic CD8 T cells in the hypothalamus, upregulation of MHC class I molecules, and destruction of vasopressin-expressing neurons. IFN-γ production by the pathogenic CD8 T cells was necessary for MHC class I upregulation by hypothalamic neurons and their destruction. This novel mouse model, in combination with related human data, supports the concept that autoreactive CD8 T cells can trigger central diabetes insipidus.

[1]  Christian G Bien,et al.  Autoantibodies associated with diseases of the CNS: new developments and future challenges , 2011, The Lancet Neurology.

[2]  R. Liblau,et al.  Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models. , 2011, Biochimica et biophysica acta.

[3]  H. Wiendl,et al.  CD8+ T cells and neuronal damage: direct and collateral mechanisms of cytotoxicity and impaired electrical excitability , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  J. Perheentupa,et al.  Clinical manifestations and management of patients with autoimmune polyendocrine syndrome type I , 2009, Journal of internal medicine.

[5]  J. Lünemann,et al.  Antiviral immune responses: triggers of or triggered by autoimmunity? , 2009, Nature Reviews Immunology.

[6]  C. Yedinak,et al.  Anti-CTLA-4 antibody therapy associated autoimmune hypophysitis: serious immune related adverse events across a spectrum of cancer subtypes , 2009, Pituitary.

[7]  Bradford Z. Mahon,et al.  Category-Specific Organization in the Human Brain Does Not Require Visual Experience , 2009, Neuron.

[8]  H. Lassmann,et al.  Cutting Edge: Multiple Sclerosis-Like Lesions Induced by Effector CD8 T Cells Recognizing a Sequestered Antigen on Oligodendrocytes1 , 2008, The Journal of Immunology.

[9]  W. Rostène,et al.  Chemokines: a new class of neuromodulator? , 2007, Nature Reviews Neuroscience.

[10]  R. Lorini,et al.  Idiopathic central diabetes insipidus in children and young adults is commonly associated with vasopressin‐cell antibodies and markers of autoimmunity , 2006, Clinical endocrinology.

[11]  K. Waki,et al.  A Case of Lymphocytic Infundibuloneurohypophysitis: Histophathological Studies , 1999, Pituitary.

[12]  R. Darnell,et al.  Paraneoplastic syndromes involving the nervous system. , 2003, The New England journal of medicine.

[13]  G. Katzos,et al.  Castleman’s Disease Presenting as a Goiter in a Child , 2003, Hormone Research in Paediatrics.

[14]  T. Lemberger,et al.  A CamKIIalpha iCre BAC allows brain-specific gene inactivation. , 2001, Genesis.

[15]  J. G. Verbalis,et al.  Diabetes insipidus. , 1997, Current therapy in endocrinology and metabolism.

[16]  K. Nagashima,et al.  Diabetes insipidus caused by lymphocytic infundibuloneurohypophysitis. , 1989, Archives of pathology & laboratory medicine.

[17]  K. Kristensson,et al.  Early major histocompatibility complex (MHC) class I antigen induction in hypothalamic supraoptic and paraventricular nuclei in trypanosome-infected rats , 1989, Journal of Neuroimmunology.